Latest conference

Title Event Dates
16th H3Africa Consortium Meeting: Fellows Call for Abstracts Monday, September 7, 2020 to Friday, September 11, 2020
16th H3Africa Consortium Meeting Monday, September 7, 2020 to Friday, September 11, 2020
15th H3Africa Consortium Meeting - Emara Ole Sereni, Nairobi, Kenya Sunday, March 8, 2020 to Friday, March 13, 2020
14th H3Africa Consortium Meeting Travel Fellowship - Accra, Ghana Sunday, September 22, 2019 to Friday, September 27, 2019
14th H3Africa Consortium Meeting - Accra, Ghana Sunday, September 22, 2019 to Friday, September 27, 2019


Latest Events

Type Title Opening / Closing date
Workshop Successes and failures of grants writing Tuesday, September 15, 2020 - 14:00 to 15:30
Distance learning Ethics and Human Subject Protection: A Refresher Course Wednesday, November 6, 2019 (All day)
Workshop Fellows' Professional Development Workshop Cape Town Wednesday, July 24, 2019 - 08:30 to Friday, July 26, 2019 - 17:00


Spotlight - H3Africa Study Coordinator

Ms. Temilola Yusuf is a study coordinator for the H3Africa’s African Female Breast Cancer Epidemiology (AFBRECANE) Project (PI: Prof. Clement Adebamowo). A multi-site project in Nigeria, AFBRECANE is a case-cohort study of genomic and epidemiological risk factors of molecular subtypes of breast cancer in African women. It also explores new diagnostic, predictive and prognostic methods within the continuum of care of breast cancer patients.
Temilola holds a Bachelor’s degree and a Master’s degree in Pharmacology & Therapeutics from Olabisi Onabanjo University, Ago-Iwoye and University of Ibadan, Ibadan, Nigeria respectively. She has received extensive trainings and has vast hands-on experience in epidemiology, genomics, bioethics and qualitative studies. Her core areas of interest lie in pharmacoepidemiology and genomics of non-communicable diseases particularly cancer and malaria as well as ethical conduct of biomedical research.
She is presently a Research Associate at the Center for Bioethics and Research (CBR), Ibadan, Nigeria, where she is progressively building a career in Pharmacogenomics and Bioethics. Prior to AFBRECANE, she was part of the INDIGENE study team and coordinated the Moderate Alcohol and Cardiovascular Health (MACH15) Trial in Nigeria. You can reach Temilola via; +234 806 165 1175.